← Back to headlines
Jeito Capital Secures Over $1.2 Billion for New Biopharma Investments
Jeito Capital has successfully raised more than $1.2 billion in funding, which will be allocated towards new investments within the biopharmaceutical sector.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
